What clients are saying
We selected the TM Capital team based on their prior experience with UltiMed and their expertise in transactions in the diabetes and animal health sectors. TM Capital did an outstanding job of presenting UltiMed’s many strengths and growth opportunities to the market, and their deep relationships with potential acquirers were key to our success. We particularly appreciate the senior team focus they brought to completing this transaction despite the emergence of the COVID pandemic in the midst of this assignment.
John Martin
VP of Corporate Development, LDI, Ltd.
Medical Products Thought Leadership
Medical Products Senior Investment Banking Team
James I. McLaren
Managing Director
Michael S. Goldman
Managing Director
Please reach out to our Medical Products investment banking team if you would like to confidentially discuss market dynamics or a potential transaction regarding your business.